The Efficacy and Safety of Nivolumab Plus mFOLFOX6 in Gastric Cancer with Severe Peritoneal Metastasis.

Autor: Nakayama Y; Third Department of Internal Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan., Ando T; Third Department of Internal Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan., Takahashi N; Department of Gastroenterology, Kouseiren Takaoka Hospital, 5-10 Eirakumachi, Takaoka-shi 933-8555, Japan., Tsukada K; Department of Gastroenterology, Kouseiren Takaoka Hospital, 5-10 Eirakumachi, Takaoka-shi 933-8555, Japan., Takagi H; Department of Medical Oncology, Toyama Prefectural Central Hospital, 2-2-78 Nishinagae, Toyama-shi 930-8550, Japan., Goto Y; Department of Gastroenterology, Takaoka City Hospital, 4-1 Takaramachi, Takaoka-shi 933-8550, Japan., Nakaya A; Department of Gastroenterology, Takaoka City Hospital, 4-1 Takaramachi, Takaoka-shi 933-8550, Japan., Nakada N; Department of Gastroenterology, Itoigawa General Hospital, 457-1 Takegahana, Itoigawa-shi 941-8502, Japan., Yoshita H; Department of Gastroenterology, Toyama Nishi General Hospital, 1019 Fuchumachi Shimokutsuwada, Toyama-shi 939-2716, Japan., Motoo I; Third Department of Internal Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan., Ueda A; Third Department of Internal Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan., Ueda Y; Third Department of Internal Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan., Sakumura M; Third Department of Internal Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan., Kajiura S; Third Department of Internal Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan., Ogawa K; Department of Medical Oncology, Toyama Prefectural Central Hospital, 2-2-78 Nishinagae, Toyama-shi 930-8550, Japan., Hosokawa A; Department of Clinical Oncology, University of Miyazaki Hospital, Kihara-5200 Kiyotakecho, Miyazaki-shi 889-1692, Japan., Yasuda I; Third Department of Internal Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.

Publikováno v: Journal of clinical medicine [J Clin Med] 2024 Jan 31; Vol. 13 (3). Date of Electronic Publication: 2024 Jan 31.

P-108 A phase II study of weekly paclitaxel in patients with advanced or recurrent esophageal cancer who had previously received docetaxel-containing chemotherapy

Autor: Ando, T., Nakashima, K., Yoshita, H., Sakumura, M., Nomura, M., Muto, M., Fujii, H., Horie, Y., Takeda, H., Yoshii, T., Tahara, Y., Katada, C., Yoshimura, K., Ishikawa, H., Hosokawa, A.

Publikováno v: In Annals of Oncology June 2022 33 Supplement 4:S288-S288

168P - A retrospective multicenter study evaluating the efficacy and safety of irinotecan in patients with advanced gastric cancer: Analysis of Glasgow Prognostic Score (GPS)

Autor: Honda, T., Nakano, S., Yuki, S., Sawada, K., Muranaka, T., Kawamoto, Y., Nakatsumi, H., Yoshita, H., Ando, T., Harada, K., Kobayashi, Y., Miyagishima, T., Hatanaka, K., Tanimoto, A., Ishiguro, A., Dazai, M., Sasaki, T., Komatsu, Y.

Publikováno v: In Annals of Oncology November 2019 30 Supplement 9:ix58-ix58

P-011 - The comparison between UGT1A1 single heterozygous and wild-type regarding the clinical outcomes of fixed-dose irinotecan monotherapy for advanced gastric cancer: a multicenter retrospective study

Autor: Ando, T., Nakano, S., Yuki, S., Sawada, K., Muranaka, T., Kawamoto, Y., Nakatsumi, H., Yoshita, H., Harada, K., Kobayashi, Y., Miyagishima, T., Hatanaka, K., Tanimoto, A., Ishiguro, A., Honda, T., Sasaki, T., Dazai, M., Komatsu, Y.

Publikováno v: In Annals of Oncology July 2019 30 Supplement 4:iv3-iv3

155P - First report: A retrospective trial for evaluating the safety and efficacy of TAS-102 for patients with metastatic colorectal cancer: HGCSG1503

Autor: Yoshita, H., Yuki, S., Yagisawa, M., Tsuji, Y., Kobayashi, Y., Hatanaka, K., Okuda, H., Dazai, M., Furukawa, K., Ogawa, K., Minami, S., Ishiguro, A., Honda, T., Ohta, T., Eto, K., Kato, T., Nakajima, J., Sasaki, T., Sakata, Y., Komatsu, Y.

Publikováno v: In Annals of Oncology November 2017 28 Supplement 10:x46-x46